Pages that link to "Q48343313"
Jump to navigation
Jump to search
The following pages link to HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement (Q48343313):
Displayed 50 items.
- Kappa opioids promote the proliferation of astrocytes via Gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways (Q24643003) (← links)
- Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine (Q24796371) (← links)
- Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism (Q24813383) (← links)
- Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic Pain (Q26768068) (← links)
- Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder (Q26865707) (← links)
- Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro (Q28354326) (← links)
- Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcription (Q28474433) (← links)
- A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse cases (Q28477511) (← links)
- Modeling the Effects of Morphine on Simian Immunodeficiency Virus Dynamics (Q28554352) (← links)
- Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials (Q30452156) (← links)
- Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction. (Q30569766) (← links)
- Alcoholism and AIDS: magnetic resonance imaging approaches for detecting interactive neuropathology (Q30712330) (← links)
- Morphine increases hippocampal viral load and suppresses frontal lobe CCL5 expression in the LP-BM5 AIDS model (Q33632272) (← links)
- Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine (Q33653493) (← links)
- Effects of vitamin A deficiency and opioids on parvalbumin + interneurons in the hippocampus of the HIV-1 transgenic rat. (Q33754498) (← links)
- Fulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug users (Q33831555) (← links)
- Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis (Q33842214) (← links)
- Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. (Q33850041) (← links)
- Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model. (Q33861574) (← links)
- Preclinical psychopharmacology of AIDS-associated dementia: lessons to be learned from the cognitive psychopharmacology of other dementias (Q34098757) (← links)
- Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload. (Q34197724) (← links)
- HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines (Q34797566) (← links)
- HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients (Q34922069) (← links)
- HIV-1 infection in injection drug users (Q34950625) (← links)
- HIV-1 and morphine regulation of autophagy in microglia: limited interactions in the context of HIV-1 infection and opioid abuse (Q34990993) (← links)
- Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors (Q35007339) (← links)
- HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse (Q35009465) (← links)
- Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. (Q35009483) (← links)
- Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro. (Q35019404) (← links)
- Sensitization of enteric neurons to morphine by HIV-1 Tat protein. (Q35236345) (← links)
- Cannabinoid neuroimmune modulation of SIV disease (Q35529056) (← links)
- Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways (Q35609910) (← links)
- Chronic SIV and morphine treatment increases heat shock protein 5 expression at the synapse (Q35650353) (← links)
- Editorial NeuroAIDS review (Q35731648) (← links)
- Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model (Q35751830) (← links)
- Toll-like receptor expression and activation in astroglia: differential regulation by HIV-1 Tat, gp120, and morphine. (Q35779664) (← links)
- Disruption of gut homeostasis by opioids accelerates HIV disease progression (Q35782918) (← links)
- Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain (Q35857045) (← links)
- An update on the neuropathology of HIV in the HAART era. (Q35966034) (← links)
- Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder (Q35996523) (← links)
- Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice. (Q36109980) (← links)
- Morphine modulation of toll-like receptors in microglial cells potentiates neuropathogenesis in a HIV-1 model of coinfection with pneumococcal pneumoniae (Q36157637) (← links)
- Opiate drug use and the pathophysiology of neuroAIDS. (Q36201412) (← links)
- The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. (Q36249104) (← links)
- The shifting patterns of HIV encephalitis neuropathology (Q36302049) (← links)
- Molecular targets of opiate drug abuse in neuroAIDS. (Q36302053) (← links)
- Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice. (Q36432328) (← links)
- Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites (Q36583732) (← links)
- Morphine exposure during HIV encephalitis in SCID mice (Q36687603) (← links)
- Neuropathologic contributions to understanding AIDS and the central nervous system (Q36771870) (← links)